DK157541C - Fremgangsmaade til fremstilling af pirbuterol og analoge forbindelser - Google Patents

Fremgangsmaade til fremstilling af pirbuterol og analoge forbindelser

Info

Publication number
DK157541C
DK157541C DK052182A DK52182A DK157541C DK 157541 C DK157541 C DK 157541C DK 052182 A DK052182 A DK 052182A DK 52182 A DK52182 A DK 52182A DK 157541 C DK157541 C DK 157541C
Authority
DK
Denmark
Prior art keywords
pirbuterol
procedure
preparation
analogical
compounds
Prior art date
Application number
DK052182A
Other languages
Danish (da)
English (en)
Other versions
DK52182A (da
DK157541B (da
Inventor
Jr Berkeley Wendell Cue
Stephen Sargent Massett
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DK52182A publication Critical patent/DK52182A/da
Priority to DK180986A priority Critical patent/DK180986D0/da
Publication of DK157541B publication Critical patent/DK157541B/da
Application granted granted Critical
Publication of DK157541C publication Critical patent/DK157541C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/65One oxygen atom attached in position 3 or 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK052182A 1981-02-09 1982-02-08 Fremgangsmaade til fremstilling af pirbuterol og analoge forbindelser DK157541C (da)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DK180986A DK180986D0 (da) 1981-02-09 1986-04-21 Fremgangsmaade til fremstilling af pirbuterol og analoge forbindelser

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23292381A 1981-02-09 1981-02-09
US23292381 1981-02-09

Publications (3)

Publication Number Publication Date
DK52182A DK52182A (da) 1982-09-17
DK157541B DK157541B (da) 1990-01-22
DK157541C true DK157541C (da) 1990-06-11

Family

ID=22875140

Family Applications (1)

Application Number Title Priority Date Filing Date
DK052182A DK157541C (da) 1981-02-09 1982-02-08 Fremgangsmaade til fremstilling af pirbuterol og analoge forbindelser

Country Status (26)

Country Link
EP (4) EP0058072A3 (ru)
JP (4) JPS57150665A (ru)
KR (1) KR860000623B1 (ru)
AR (4) AR231439A1 (ru)
AT (2) ATE20882T1 (ru)
AU (1) AU530826B2 (ru)
CA (1) CA1179677A (ru)
CS (1) CS229678B2 (ru)
DD (2) DD210034A5 (ru)
DE (2) DE3272793D1 (ru)
DK (1) DK157541C (ru)
EG (1) EG16242A (ru)
ES (4) ES509430A0 (ru)
FI (1) FI820396L (ru)
GR (1) GR75867B (ru)
GT (1) GT198273686A (ru)
IE (2) IE52325B1 (ru)
IL (1) IL64954A (ru)
NO (4) NO820371L (ru)
NZ (1) NZ199646A (ru)
PH (4) PH20622A (ru)
PL (4) PL130678B1 (ru)
PT (1) PT74397B (ru)
SU (4) SU1194273A3 (ru)
YU (3) YU42756B (ru)
ZA (1) ZA82778B (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3615293A1 (de) * 1986-05-06 1987-11-12 Bayer Ag Verwendung von heteroarylethylaminen zur leistungsfoerderung bei tieren, heteroarylethylamine und verfahren zu ihrer herstellung

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3700681A (en) * 1971-02-16 1972-10-24 Pfizer 2-hydroxymethyl-3-hydroxy-6-(1-hydroxy-2-aminoethyl)pyridines
BE795937A (fr) * 1972-03-01 1973-08-27 Pepro Procede d'hydroxymethylation d'une 3-hydroxy-pyridine substituee
AR207639A1 (es) * 1973-12-26 1976-10-22 Pfizer Un procedimiento para preparar pirido (3,2-d)1,3-dioxin-6-epoxietanos y compuestos intermediarios desprovistos de actividad terapeutica
US4031108A (en) * 1974-10-09 1977-06-21 Pfizer Inc. 2-Hydroxymethyl-3-benzyloxypyridine-6-epoxyethane
US3952101A (en) * 1975-04-14 1976-04-20 Smithkline Corporation α-Amino methyl-5-hydroxy-2-pyridinemethanols

Also Published As

Publication number Publication date
JPS57150665A (en) 1982-09-17
DE3272061D1 (en) 1986-08-28
ATE20882T1 (de) 1986-08-15
IE52325B1 (en) 1987-09-16
EP0058071B1 (en) 1986-07-23
FI820396L (fi) 1982-08-10
PL130678B1 (en) 1984-08-31
JPS60208962A (ja) 1985-10-21
KR860000623B1 (ko) 1986-05-24
ES518973A0 (es) 1984-03-01
AU8027182A (en) 1982-08-19
SU1194273A3 (ru) 1985-11-23
PT74397B (en) 1984-10-09
PH20622A (en) 1987-03-06
ES518972A0 (es) 1984-03-01
PL130918B1 (en) 1984-09-29
GR75867B (ru) 1984-08-02
JPS6059911B2 (ja) 1985-12-27
YU26682A (en) 1985-04-30
PT74397A (en) 1982-03-01
EP0058071A2 (en) 1982-08-18
ES8403112A1 (es) 1984-03-01
NO824273L (no) 1982-08-10
IE820273L (en) 1982-08-09
YU201884A (en) 1985-04-30
IL64954A (en) 1986-03-31
JPS6135184B2 (ru) 1986-08-12
AR229373A1 (es) 1983-07-29
SU1240354A3 (ru) 1986-06-23
JPS6059231B2 (ja) 1985-12-24
EP0058072A3 (en) 1982-08-25
EP0058070A2 (en) 1982-08-18
DD202544A5 (de) 1983-09-21
DK52182A (da) 1982-09-17
EG16242A (en) 1989-01-30
CS229678B2 (en) 1984-06-18
JPS6119624B2 (ru) 1986-05-17
SU1217253A3 (ru) 1986-03-07
EP0058069A3 (en) 1982-09-01
ES518971A0 (es) 1984-03-01
AU530826B2 (en) 1983-07-28
EP0058071A3 (en) 1982-08-25
PL239426A1 (en) 1983-04-25
EP0058072A2 (en) 1982-08-18
DK157541B (da) 1990-01-22
PL130917B1 (en) 1984-09-29
NO824275L (no) 1982-08-10
YU201984A (en) 1985-04-30
EP0058069A2 (en) 1982-08-18
IE52326B1 (en) 1987-09-16
PL130580B1 (en) 1984-08-31
DE3272793D1 (en) 1986-10-02
PL239428A1 (en) 1983-04-25
JPS60208964A (ja) 1985-10-21
IL64954A0 (en) 1982-04-30
ES8403111A1 (es) 1984-03-01
AR229712A1 (es) 1983-10-31
GT198273686A (es) 1983-07-30
SU1250170A3 (ru) 1986-08-07
YU42908B (en) 1988-12-31
YU43389B (en) 1989-06-30
AR231439A1 (es) 1984-11-30
IE820275L (en) 1982-08-09
DD210034A5 (de) 1984-05-30
PH19164A (en) 1986-01-16
ES8403110A1 (es) 1984-03-01
NO820371L (no) 1982-08-10
ES8305721A1 (es) 1983-04-16
CA1179677A (en) 1984-12-18
PL239427A1 (en) 1983-04-25
NZ199646A (en) 1985-11-08
EP0058070A3 (en) 1982-08-25
YU42756B (en) 1988-12-31
ATE21691T1 (de) 1986-09-15
JPS6193164A (ja) 1986-05-12
EP0058069B1 (en) 1986-08-27
AR229374A1 (es) 1983-07-29
ES509430A0 (es) 1983-04-16
ZA82778B (en) 1983-01-26
KR830009028A (ko) 1983-12-17
PL235000A1 (en) 1983-04-11
NO824274L (no) 1982-08-10
PH19167A (en) 1986-01-16
PH20292A (en) 1986-11-18

Similar Documents

Publication Publication Date Title
DK155665C (da) Analogifremgangsmaade til fremstilling af carbostyrilforbindelser
DK65882A (da) Fremgangsmaade til fremstilling af substituerede phosphonamider
DK497682A (da) Fremgangsmaade til fremstilling af 7-oxabicycloheptan- og 7-oxabicycloheptenprostaglandinanaloge
DK443282A (da) Cykliske dihydroxyforbindelser og fremgangsmaade til fremstilling af cykliske dihydroxyforbindelser
DK157193C (da) Analogifremgangsmaade til fremstilling af carbostyrilforbindelser
DK498080A (da) Fremgangsmaade til fremstilling af 4!-epidaunorubicin, 3!,4!-diepidaunorubicin og disses doxorubicinanaloge
DK132779A (da) Fremgangsmaade til fremstilling af cishexahydrodibenzoepyranoner og tetrahydrobenzoxoiner
DK153282A (da) Fremgangsmaade til fremstilling af bismethinisoindoliner
DK239382A (da) Fremgangsmaade til fremstilling af anthracyclinglycosider
DK113079A (da) Fremgangsmaade til fremstilling af n-oxacyclylalkyl-piperidyl-diazaforbindelser og anvendelsen deraf
DK163379A (da) Fremgangsmaade til fremstilling af substituerede 1,3-diaryl-2-imino-imidazolidiner og 2-imino-hexahydro-pyrimidiner
DK314081A (da) Fremgangsmaade og anlaeg til fremstilling af alfagipssemihydrat
DK305982A (da) Fremgangsmaade til fremstilling af amidobenzamider
DK364481A (da) Fremgangsmaade til fremstilling af caprylolactamer
DK156510C (da) Fremgangsmaade til fremstilling af cement og indretning til udoevelse af fremgangsmaaden
DK381984D0 (da) Fremgangsmaade til fremstilling af aspartam
DK296281A (da) Fremgangsmaade til fremstilling af aminocyklopentanonamider
DK287484A (da) Fremgangsmaade til fremstilling af acetaldehyd
DK149944C (da) Polymert dispergeringsmiddel og fremgangsmaader til fremstilling af samme
DK579181A (da) Fremgangsmaade til fremstilling af diarylthiophener
DK153841C (da) Fremgangsmaade til fremstilling af ranitidin
DK12581A (da) Fremgangsmaade til fremstilling af kijanimicin
DK157541C (da) Fremgangsmaade til fremstilling af pirbuterol og analoge forbindelser
DK151274C (da) Fremgangsmaade til fremstilling af meldroejealkaloider, isaer ergokornin og beta-ergokryptin
DK605384D0 (da) Fremgangsmaade til fremstilling af azetidinoner

Legal Events

Date Code Title Description
PUP Patent expired